Find information on thousands of medical conditions and prescription drugs.

Tricuspid atresia

Tricuspid atresia is a form of congenital heart disease whereby there is a complete absence of the tricuspid valve. Therefore, there is an absence of right atrioventricular connection. This leads to a hypoplastic or an absence of the right ventricle. more...

Home
Diseases
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
Candidiasis
Tachycardia
Taeniasis
Talipes equinovarus
TAR syndrome
Tardive dyskinesia
Tarsal tunnel syndrome
Tay syndrome ichthyosis
Tay-Sachs disease
Telangiectasia
Telangiectasia,...
TEN
Teratoma
Teratophobia
Testotoxicosis
Tetanus
Tetraploidy
Thalassemia
Thalassemia major
Thalassemia minor
Thalassophobia
Thanatophobia
Thoracic outlet syndrome
Thrombocytopenia
Thrombocytosis
Thrombotic...
Thymoma
Thyroid cancer
Tick paralysis
Tick-borne encephalitis
Tietz syndrome
Tinnitus
Todd's paralysis
Topophobia
Torticollis
Touraine-Solente-Golé...
Tourette syndrome
Toxic shock syndrome
Toxocariasis
Toxoplasmosis
Tracheoesophageal fistula
Trachoma
Transient...
Transient Global Amnesia
Transposition of great...
Transverse myelitis
Traumatophobia
Treacher Collins syndrome
Tremor hereditary essential
Trichinellosis
Trichinosis
Trichomoniasis
Trichotillomania
Tricuspid atresia
Trigeminal neuralgia
Trigger thumb
Trimethylaminuria
Triplo X Syndrome
Triploidy
Trisomy
Tropical sprue
Tropophobia
Trypanophobia
Tuberculosis
Tuberous Sclerosis
Tularemia
Tungiasis
Turcot syndrome
Turner's syndrome
Typhoid
Typhus
Tyrosinemia
U
V
W
X
Y
Z
Medicines

Because of the lack of an A-V connection, an atrial septal defect (ASD) must be present to maintain blood flow. Also, since there is a lack of a right ventricle there must be a way to pump blood into the pulmonary arteries, and this is accomplished by a ventricular septal defect (VSD).

Blood is mixed in the left atrium. Because the only way the pulmonary circulation receives blood is through the VSD, a patent ductus arteriosus is usually also formed to increase pulmonary flow.

Clinical manifestations

  • progressive cyanosis
  • poor feeding
  • tachypnea over the first 2 weeks of life
  • holosystolic murmur due to the VSD
  • superior axis and left ventricular hypertrophy (since it must pump blood to both the pulmonary and systemic systems)
  • normal heart size

Treatment

  • PGE1 to maintain patent ductus arteriosus
  • modified Blalock-Taussig shunt to maintain pulmonary blood flow by placing a Gortex conduit between the subclavian artery and the pulmonary artery.
  • cavopulmonary anastomosis (hemi-Fontan or bidirectional Glenn) to provide stable pulmonary flow
  • Fontan procedure to redirect inferior vena cava and hepatic vein flow into the pulmonary circulation

External Links

  • Tricuspid Atresia information from Seattle Children's Hospital Heart Center

Read more at Wikipedia.org


[List your site here Free!]


Screening for congenital cardiovascular malformations - Tips from Other Journals - Author Abstract
From American Family Physician, 10/15/03 by Sumi M. Sexton

Congenital cardiovascular malformations (CCVMs) occur in five to 10 infants out of 1,000 live births and are associated with significant morbidity and mortality. Although a four-chamber view enables the detection of many malformations, the cost of routine fetal echocardiography makes it an impractical screening tool. Preliminary studies suggest that pulse oximetry may be an effective screening tool for hypoplastic left heart syndrome, coarctation, D transposition of the great arteries, pulmonary atresia with intact ventricular septum, tricuspid atresia, total anomalous pulmonary venous return, and tetralogy of Fallot in asymptomatic newborns. Suggested limitations of oximetry screening are aortic stenosis and coarctation with large ventricular septal defect. Koppel and colleagues determined the sensitivity, specificity, predictive value, and accuracy of pulse oximetry in detecting CCVMs in asymptomatic newborns.

A total of 11,281 asymptomatic newborns from the well-infant nurseries of two hospitals were included in the study. Exclusion criteria were any of the following abnormalities found on examination: cyanosis, tachypnea, grunting, flaring, retraction, murmur, active precordium, and diminished pulses. A single postductal oxygen saturation level was obtained at the time of metabolic screening in one hospital and on discharge in the other hospital. All newborns with 95 percent or less saturation underwent echocardiography.

Pulse oximetry detected three cases of CCVM (true positives), and two cases were diagnosed after discharge (false negatives). The false-negative cases were coarctation and hypoplastic left pulmonary artery with aortopulmonary collaterals, conditions that may not cause desaturation. Four echocardiograms were obtained, detecting three CCVMs and one case of delayed transition from fetal to neonatal circulation and self-limited pulmonary hypertension. Analysis showed a sensitivity of 60 percent, specificity of 99.95 percent, positive predictive value of 75 percent, negative predictive value of 99.98 percent, and accuracy of 99.97 percent. Of note, screening fetal echocardiography was more frequently used in one hospital (revealing nine CCVMs), which explains why rates of detection of CCVMs via pulse oximetry were lower in that hospital.

The authors conclude that in hospitals with lower rates of fetal echocardiography, pulse oximetry is a simple, reliable, and cost-effective screening test for CCVM in asymptomatic newborns.

Koppel RI, et al. Effectiveness of pulse oximetry screening for congenital heart disease in asymptomatic newborns. Pediatrics March 2003;111:451-5.

COPYRIGHT 2003 American Academy of Family Physicians
COPYRIGHT 2003 Gale Group

Return to Tricuspid atresia
Home Contact Resources Exchange Links ebay